These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34024771)

  • 1. Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module.
    Berti B; Fanelli L; de Sanctis R; Onesimo R; Palermo C; Leone D; Carnicella S; Norcia G; Forcina N; Coratti G; Giorgio V; Cerchiari A; Lucibello S; Finkel R; Pane M; Mercuri E
    J Neuromuscul Dis; 2021; 8(4):589-601. PubMed ID: 34024771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexible endoscopic evaluation of swallowing in children with type 1 spinal muscular atrophy.
    Zang J; Johannsen J; Denecke J; Weiss D; Koseki JC; Nießen A; Müller F; Nienstedt JC; Flügel T; Pflug C
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1329-1338. PubMed ID: 36209319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feeding and Swallowing Problems in Infants with Spinal Muscular Atrophy Type 1: an Observational Study.
    van der Heul AMB; Cuppen I; Wadman RI; Asselman F; Schoenmakers MAGC; van de Woude DR; Gerrits E; van der Pol WL; van den Engel-Hoek L
    J Neuromuscul Dis; 2020; 7(3):323-330. PubMed ID: 32333596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trajectory of change in the swallowing status in spinal muscular atrophy type I.
    Choi YA; Suh DI; Chae JH; Shin HI
    Int J Pediatr Otorhinolaryngol; 2020 Mar; 130():109818. PubMed ID: 31945686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swallowing Problems in Spinal Muscular Atrophy Types 2 and 3: A Clinical, Videofluoroscopic and Ultrasound Study.
    van der Heul AMB; Nievelstein RAJ; van Eijk RPA; Asselman F; Erasmus CE; Cuppen I; Bittermann AJN; Gerrits E; van der Pol WL; van den Engel-Hoek L
    J Neuromuscul Dis; 2023; 10(3):427-438. PubMed ID: 37005890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors for feeding and swallowing difficulties in spinal muscular atrophy types II and III.
    Chen YS; Shih HH; Chen TH; Kuo CH; Jong YJ
    J Pediatr; 2012 Mar; 160(3):447-451.e1. PubMed ID: 21924737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral and Swallowing Abilities Tool (OrSAT) in nusinersen treated patients.
    Berti B; Fanelli L; Stanca G; Onesimo R; Palermo C; Leone D; de Sanctis R; Carnicella S; Norcia G; Forcina N; Coratti G; Pera MC; Giorgio V; Ausili Cefaro C; Finkel R; Pane M; Mercuri E
    Arch Dis Child; 2022 Sep; 107(10):912-916. PubMed ID: 35577540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a screening tool for feeding/swallowing difficulties and undernutrition in children with cerebral palsy.
    Bell KL; Benfer KA; Ware RS; Patrao TA; Garvey JJ; Arvedson JC; Boyd RN; Davies PSW; Weir KA
    Dev Med Child Neurol; 2019 Oct; 61(10):1175-1181. PubMed ID: 30937885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive treatment strategy for swallowing problems related to prolonged nonoral feeding in spinal muscular atrophy type II.
    Cha TH; Oh DW; Shim JH
    Dysphagia; 2010 Sep; 25(3):261-4. PubMed ID: 20087605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Bulbar Function in Spinal Muscular Atrophy Using Patient-Reported Outcomes.
    Dunaway Young S; Pasternak A; Duong T; McGrattan KE; Stranberg S; Maczek E; Dias C; Tang W; Parker D; Levine A; Rohan A; Wolford C; Martens W; McDermott MP; Darras BT; Day JW
    J Neuromuscul Dis; 2023; 10(2):199-209. PubMed ID: 36776075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bulbar Problems Self-Reported by Children and Adults with Spinal Muscular Atrophy.
    van der Heul AMB; Wijngaarde CA; Wadman RI; Asselman F; van den Aardweg MTA; Bartels B; Cuppen I; Gerrits E; van den Berg LH; van der Pol WL; van den Engel-Hoek L
    J Neuromuscul Dis; 2019; 6(3):361-368. PubMed ID: 31476167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of type I spinal muscular atrophy with noninvasive ventilation and gastrostomy feeding.
    Birnkrant DJ; Pope JF; Martin JE; Repucci AH; Eiben RM
    Pediatr Neurol; 1998 May; 18(5):407-10. PubMed ID: 9650680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feeding problems and malnutrition in spinal muscular atrophy type II.
    Messina S; Pane M; De Rose P; Vasta I; Sorleti D; Aloysius A; Sciarra F; Mangiola F; Kinali M; Bertini E; Mercuri E
    Neuromuscul Disord; 2008 May; 18(5):389-93. PubMed ID: 18420410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysphagia in spinal muscular atrophy type II: more than a bulbar problem?
    van den Engel-Hoek L; Erasmus CE; van Bruggen HW; de Swart BJ; Sie LT; Steenks MH; de Groot IJ
    Neurology; 2009 Nov; 73(21):1787-91. PubMed ID: 19933981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feeding difficulties in children and adolescents with spinal muscular atrophy type 2.
    Wadman RI; De Amicis R; Brusa C; Battezzati A; Bertoli S; Davis T; Main M; Manzur A; Mastella C; Munot P; Imbrigiotta N; Schottlaender L; Sarkozy A; Trucco F; Baranello G; Scoto M; Muntoni F
    Neuromuscul Disord; 2021 Feb; 31(2):101-112. PubMed ID: 33454188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative study of perceptions of meaningful change in spinal muscular atrophy.
    McGraw S; Qian Y; Henne J; Jarecki J; Hobby K; Yeh WS
    BMC Neurol; 2017 Apr; 17(1):68. PubMed ID: 28376816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale.
    Werlauff U; Højberg A; Firla-Holme R; Steffensen BF; Vissing J
    Qual Life Res; 2014 Jun; 23(5):1479-88. PubMed ID: 24214178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).
    Stam M; Wadman RI; Wijngaarde CA; Bartels B; Asselman FL; Otto LAM; Goedee HS; Habets LE; de Groot JF; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    BMJ Open; 2018 Jul; 8(7):e019932. PubMed ID: 30061431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful botulinum toxin treatment of dysphagia in a spinal muscular atrophy type 2 patient.
    Suzukia Y; Sano N; Shinonaga C; Fukuda M; Hyodo M; Morimoto T
    Brain Dev; 2007 Nov; 29(10):662-5. PubMed ID: 17532160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.